PEG
62
-2
PRU
62
-2
DE
62
-3
WM
76
-3
GE
67
2
NWS
90
26
DGX
39
2
HPQ
53
-3
DTE
52
-2
MS
62
-7
AON
50
-4
ADM
33
-4
KHC
15
-2
VRSN
58
-2
AIG
41
-4
GS
68
-5
IP
67
2
RIG
61
3
BAX
33
-3
LLY
57
4
PEG
62
-2
PRU
62
-2
DE
62
-3
WM
76
-3
GE
67
2
NWS
90
26
DGX
39
2
HPQ
53
-3
DTE
52
-2
MS
62
-7
AON
50
-4
ADM
33
-4
KHC
15
-2
VRSN
58
-2
AIG
41
-4
GS
68
-5
IP
67
2
RIG
61
3
BAX
33
-3
LLY
57
4
Financhill
Back

NovoCure Vs. Perspective Therapeutics Industry Stock Comparison

Buy
77

NVCR
NovoCure

Last Price:
29.28
Seasonality Move:
2.04%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.70
Seasonality Move:
28.47%
Buy
77
NovoCure (NVCR) is a Buy

Is NovoCure a Buy, Sell or Hold?

  • The current NovoCure [NVCR] share price is $30.51. The Score for NVCR is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
  • NVCR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $4.00. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NVCR Stock Price Chart

What is NovoCure's stock price today?

  • The NovoCure share price today is $30.51
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVCR is experiencing slight selling pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $4.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight selling pressure.

NVCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.24 Buy
Relative Strength Index (14 RSI): 84.56 Buy
Chaikin Money Flow: -690353 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.69 - 22.01) Buy
Bollinger Bands (100): (15.44 - 20.28) Buy

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.15 Sell
Relative Strength Index (14 RSI): 23.56 Sell
Chaikin Money Flow: -692896 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.81 - 11.73) Sell
Bollinger Bands (100): (9.09 - 15.11) Sell

NVCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.45 Buy
20-day SMA: 18.85 Buy
50-day SMA: 17.12 Buy
200-day SMA: 17.34 Buy
8-day EMA: 23.1 Buy
20-day EMA: 19.92 Buy
50-day EMA: 18.23 Buy
200-day EMA: 19.07 Buy

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.9 Buy
20-day SMA: 7.36 Sell
50-day SMA: 10.44 Sell
200-day SMA: 12.59 Sell
8-day EMA: 4.6 Sell
20-day EMA: 6.66 Sell
50-day EMA: 9.44 Sell
200-day EMA: 10.93 Sell

NovoCure Earnings Growth & NVCR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.32 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.

NovoCure Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):